Jacques Ambrose

Psychedelic Renaissance: Clinical Health Justice, Patient Safety, and Equity Need to Be Put First

Psychiatric News February 16, 2023 Jacques Ambrose, Jeffrey S Zabinski

With the impending FDA review of the phase 3 data for MDMA-assisted psychotherapy for PTSD, experts reflect on ethical considerations, appropriate use, and access. The groundswell of interest in psychedelics in psychiatry, medicine broadly, and in popular culture continues without a peak in sight. Though the term “psychedelic” was coined in the 20th century, these compounds have an extensive...